venBio Partners’s Attovia Therapeutics ATTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$71.7M Buy
+4,181,366
New +$88M 14.45% 3

Other funds holding ATTO

venBio Partners's ATTO Position: Q3 2026 in Review

venBio Partners opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 4,181,366 shares worth $71.7M. The stake represents 14.45% of the portfolio and ranks #3 among its holdings.

57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • venBio Partners held 4,181,366 shares of Attovia Therapeutics worth $71.7M as of Q3 2026.
  • Attovia Therapeutics was a new venBio Partners position in Q3 2026.
  • Attovia Therapeutics made up 14.45% of venBio Partners's portfolio in Q3 2026, its #3 holding.
  • 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on venBio Partners's 13F filing for Q3 2026, filed 16 Nov 2026.